SSYS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SSYS is not a good buy right now for an impatient investor. The stock just sold off sharply (-4.80% regular session) and is trading below a key support area (~10.75), while momentum (MACD) is still deteriorating. Even though options positioning is call-heavy and longer-term moving averages are bullish, the near-term tape suggests you’d be buying into weakening momentum without a confirming reversal signal or proprietary buy trigger.
Trend/Momentum: Mixed-to-bearish near term. MACD histogram is negative (-0.022) and expanding lower, signaling downside momentum building. RSI(6) at 43.9 is neutral but leaning weak (not oversold), so there’s room to drift lower before a technical snapback becomes likely.
Moving averages: Bullish structure (SMA_5 > SMA_20 > SMA_200) implies the broader trend hasn’t fully broken, but the latest drop is challenging that setup.
Levels: Current ~10.7 is just below S1 (10.749), making the immediate area fragile. Next support is S2 (10.383). To turn the chart constructive quickly, price would need to reclaim the pivot (11.341) and hold above it; upside resistances are ~11.933 and ~12.299.
Pattern-based expectation: Similar-pattern analysis suggests only modest upside skew (next week +4.01%, next month +5.06%), but the near-term direction is uncertain (30% chance to ~0.09% next day).
Intellectia Proprietary Trading Signals
Losses are narrowing: Net income and EPS improved materially YoY in the latest reported quarter (still negative, but trending better).
Near-term technical deterioration: sharp down day and MACD worsening while price sits just under a key support (~10.75).
Fundamentals show pressure: 2025/Q3 revenue declined (-2.17% YoY) and gross margin dropped to 40.95% (-8.59% YoY), with tariffs cited as a headwind.
No fresh news catalyst in the past week to quickly reverse sentiment.
Institutional/insider tone is neutral (no notable supportive flow signals recently).
Latest quarter: 2025/Q3. Revenue fell to $136.97M (-2.17% YoY), indicating continued demand softness. Profitability improved versus last year but remains negative: net income improved to -$55.63M (up 109.04% YoY) and EPS improved to -$0.65 (up 75.68% YoY). Gross margin weakened to 40.95% (-8.59% YoY), consistent with commentary about tariff/macro pressure—this is a meaningful negative trend for quality of earnings.
Recent trend: modestly improving. On 2025-11-14, Cantor Fitzgerald reiterated Overweight and raised the price target to $13.50 from $13. Wall Street pros: improving loss trajectory and a supportive rating/raised target; potential upside if capital equipment spending normalizes. Wall Street cons: macro-driven capex constraints and tariff-related margin pressure are actively weighing on results, and the stock’s near-term momentum is currently weak.
